Announcements

  • IDSA, AASLD critical of Cochrane review of HCV drugs

    By: David McCombs David McCombs , 8 years ago
    Members of the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases have issued a strongly worded rebuke of a recent Cochrane review of drugs for the treatment of hepatitis C virus infection.